Company
United StatesPublic company, NYSE: LLYEli Lilly and Company (NYSE: LLY), Durham, NC – FDA Inspections
Inspection records and compliance data for Eli Lilly and Company in Durham, NC. 2 FDA inspections on record, last inspected February 26, 2025. Publicly traded as NYSE: LLY.
Company Profile
This profile covers Eli Lilly and Company based in Durham, NC, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected March 16, 2023. Last inspected February 26, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 26, 2025 | Not classified | Human Drugs | 1265205 |
| March 16, 2023 | Not classified | Human Drugs | 1200786 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Eli Lilly and Company
Stock ticker
LLY
Exchange
NYSE
Share price
$1,430.13
Market cap
$1.3T
Price as of
November 13, 2026
FEI Number
3020952692
Address
59 Moore Dr, Durham, NC 27713-2840, United States
Country
United States
ID: ba21ac40-002d-4c71-a9b1-817a58f83a2a